Roivant Sciences to join BaseLaunch Accelerator as Healthcare Partner Roivant becomes the fifth healthcare partner of BaselArea.swiss accelerator program joining Johnson & Johnson Innovation,…Jérémie Meyer01.18.2018
“We’re giving Basel Impact Hub fever” Impact Hubs are a real success story. Founded in 2005 in London, there are now…Jérémie Meyer01.09.2018
Roche and Novartis among most valuable companies The Basel pharmaceutical companies Roche and Novartis are among the 40 most valuable companies in…Jérémie Meyer01.02.2018
Novartis medication effective against psoriasis The Basel-based pharmaceutical company Novartis has released positive data on the long-term efficacy of its…Jérémie Meyer11.30.2017
Pharmaceutical industry is driving the Swiss economy The number of jobs in the pharmaceutical industry is on a steady rise – and…Jérémie Meyer11.22.2017
The changing healthcare system in China On September 15th 2017, the first Swiss-Chinese Life Sciences Forum took place at Roche in…Jérémie Meyer10.03.2017
13 startup projects qualify for the first phase of BaseLaunch The BaseLaunch Healthcare Accelerator program from BaselArea.swiss started on September 14. Over 100 applications were…Jérémie Meyer09.18.2017
Patient Data – Faster but with Respect and Trust “Faster but with Respect and Trust“ - these were the final words from Effy Vayena…Jérémie Meyer09.14.2017
Halozyme Therapeutics opens European headquarters Halozyme, a U.S. biotechnology company developing novel oncology and drug-delivery therapies, has established their European…Jérémie Meyer09.05.2017
“In Switzerland, we often sell promising technologies too early” Ulf Claesson is a "serial entrepreneur". During the past 25 years, he has set up…Jérémie Meyer09.05.2017